A Comparative Evaluation of HbA1c Measurement Methods and Their Implications for Diabetes Management
Open Access
- 15 November 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (22) , 3449
Abstract
In this study, we assessed the correlations between hemoglobin A1c (HbA1c) measurements obtained using three different diagnostic methods, namely reversed-phase cation-exchange chromatography, high-performance liquid chromatography, and lateral flow immunoassay (LIFA) with an AnyLab F instrument. HbA1c levels measured with the AnyLab F instrument and those measured with the HA8190V, HA8180, and D100 instruments were strongly correlated. High R-square values and low p-values indicated significant and reliable correlations, supporting the clinical interchangeability of these methods. Notably, demographic and clinical analyses revealed uniform HbA1c levels across age groups, suggesting minimal age-related variations in HbA1c levels in the cohort. This finding has implications for diabetes management strategies across different age groups, emphasizing the versatility of the AnyLab F instrument. Overall an average HbA1c level of 7.857% among diabetes mellitus-diagnosed participants suggests moderately elevated HbA1c levels, underscoring the need for improved diabetes management. Younger individuals exhibited lower HbA1c levels, potentially owing to heightened awareness and treatment plan adherence. Conversely, older adults had higher HbA1c levels, likely influenced by age-related changes and comorbidities. Larger sample sizes and a comprehensive evaluation of various measurement principles are needed to strengthen the findings herein. Additionally, exploring additional biomarkers and assessing LIFA performance in larger sample sets will advance the clinical utility of HbA1c measurements.Keywords
This publication has 28 references indexed in Scilit:
- HbA1c-testing: Evaluation of two point-of-care analysersPrimary Care Diabetes, 2019
- How can point-of-care HbA1c testing be integrated into UK primary care consultations? – A feasibility studyDiabetes Research and Clinical Practice, 2017
- Comparison of the point of care test (POCT), i-CHROMA™ human chorionic gonadotrophin (HCG), leutinzing hormone (LH) and follicle stimulating hormone (FSH) methods with the other laboratory methods in the Randox International Quality Assessment Scheme (RIQAS)Clinical Obstetrics, Gynecology and Reproductive Medicine, 2017
- IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetesDiabetes Research and Clinical Practice, 2016
- Evaluation of Analytical Performance of the D-100 Hemoglobin Testing System for Hemoglobin A1c AssayLaboratory Medicine and Quality Assurance, 2016
- Evaluation of the Sebia Capillarys 3 Tera and the Bio-Rad D-100 Systems for the Measurement of Hemoglobin A1cAmerican Journal of Clinical Pathology, 2016
- Evaluation of Bio-Rad D-100 HbA1c analyzer against Tosoh G8 and Menarini HA-8180VPractical Laboratory Medicine, 2016
- Analytical performances of the D-100TM hemoglobin testing system (Bio-Rad) for HbA1c assayClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Research and Clinical Practice, 2014
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009